mirror of
https://github.com/msberends/AMR.git
synced 2026-11-16 09:50:51 +01:00
(v3.0.1.9118) update doc
This commit is contained in:
1 parent
10053d582e
commit
36e6388868
8 files changed
+44
-62
No files matched your search
+1
-1
@@ -1,5 +1,5 @@
|
|||||||
Package: AMR
|
Package: AMR
|
||||||
Version: 3.0.1.9117
|
Version: 3.0.1.9118
|
||||||
Date: 2026-10-11
|
Date: 2026-10-11
|
||||||
Title: Antimicrobial Resistance Data Analysis
|
Title: Antimicrobial Resistance Data Analysis
|
||||||
Description: Functions to simplify and standardise antimicrobial resistance (AMR)
|
Description: Functions to simplify and standardise antimicrobial resistance (AMR)
|
||||||
|
|||||||
@@ -1,4 +1,4 @@
|
|||||||
# AMR 3.0.1.9117
|
# AMR 3.0.1.9118
|
||||||
|
|
||||||
Planned as v3.1.0, mid October 2026.
|
Planned as v3.1.0, mid October 2026.
|
||||||
|
|
||||||
|
|||||||
+9
-11
@@ -27,26 +27,20 @@
|
|||||||
# how to conduct AMR data analysis: https://amr-for-r.org #
|
# how to conduct AMR data analysis: https://amr-for-r.org #
|
||||||
# ==================================================================== #
|
# ==================================================================== #
|
||||||
|
|
||||||
|
|
||||||
#' Combine SIR Results of Multiple Antimicrobials
|
#' Combine SIR Results of Multiple Antimicrobials
|
||||||
#'
|
#'
|
||||||
#' @description Combine the SIR results of two or more antimicrobials into one SIR result per isolate, e.g. to create a variable `TZP_GEN` for the combination therapy of piperacillin/tazobactam with gentamicin. The result is the best result of the antimicrobials, as a combination therapy covers the isolate if any of its antimicrobials is active. See *Combination Therapy* below for the exact rules.
|
#' @description Combine the SIR results of two or more antimicrobials into one SIR result per isolate, e.g. to create a variable for the combination therapy of piperacillin/tazobactam with gentamicin. The result is the best result of the antimicrobials, as a combination therapy covers the isolate if any of its antimicrobials is active. See *Combination Therapy* below for the exact rules.
|
||||||
#'
|
#'
|
||||||
#' The same rules are used by [antibiogram()] and [wisca()] for combination antibiograms, and by the [`count_*()`][count()] and [`proportion_*()`][proportion()] functions when more than one variable is used, so the result of [sir_combine()] can be used in any further analysis.
|
#' The same rules are used by [antibiogram()] and [wisca()] for combination antibiograms, and by the [`count_*()`][count()] and [`proportion_*()`][proportion()] functions when more than one variable is used, so the result of [sir_combine()] can be used in any further analysis.
|
||||||
#' @param ... Two or more vectors (or columns) with antimicrobial interpretations, or a data frame with such columns. They will be transformed internally with [as.sir()] if needed. All vectors must be of the same length.
|
#' @param ... Two or more vectors (or columns) with antimicrobial interpretations, or a data frame with such columns. They will be transformed internally with [as.sir()] if needed. All vectors must be of the same length.
|
||||||
#' @param only_all_tested A [logical] to indicate that isolates must be tested for all antimicrobials. If `TRUE`, the result is `NA` for isolates with a missing result for any of the antimicrobials. If `FALSE` (default), a missing result only leads to `NA` if a result for the missing antimicrobial could have changed the result of the combination, see *Combination Therapy* below.
|
#' @param only_all_tested A [logical] to indicate that isolates must be tested for all antimicrobials. If `TRUE`, the result is `NA` for isolates with a missing result for any of the antimicrobials. If `FALSE` (default), a missing result only leads to `NA` if a result for the missing antimicrobial could have changed the result of the combination, see *Combination Therapy* below.
|
||||||
#' @param guideline Either `"EUCAST"` (default) or `"CLSI"`, to determine whether the 'I' category is considered susceptible. This only affects isolates with a missing result for any of the antimicrobials when `only_all_tested = FALSE`, see *Combination Therapy* below. The default can be changed with the `AMR_guideline` option, see [AMR-options].
|
#' @param guideline Either `"EUCAST"` (default) or `"CLSI"`, to determine whether the 'I' category is considered susceptible. This only affects isolates with a missing result for any of the antimicrobials when `only_all_tested = FALSE`, see *Combination Therapy* below. The default can be changed with the `AMR_guideline` option, see [AMR-options].
|
||||||
#' @section Combination Therapy:
|
#' @section Combination Therapy:
|
||||||
#' A combination of antimicrobials is considered as good as its most active antimicrobial. Results are ranked as follows, from best to worst:
|
#' A combination of antimicrobials is considered as good as its most active antimicrobial: `"S"` is preferred over `"WT"`, and `"R"` over `"NWT"` and `"NS"`. The value `"NI"` (non-interpretable) is considered a missing result.
|
||||||
#'
|
#'
|
||||||
#' 1. `"S"` and `"WT"`
|
#' A missing result can only be ignored if the result of the combination is susceptible regardless of the missing result, which depends on the `only_all_tested` argument and on the guideline: under EUCAST, the 'I' category is considered susceptible (*susceptible, increased exposure*), and under CLSI, it is not.
|
||||||
#' 2. `"SDD"`
|
|
||||||
#' 3. `"I"`
|
|
||||||
#' 4. `"R"`, `"NWT"`, and `"NS"`
|
|
||||||
#'
|
#'
|
||||||
#' The result of the combination is the best result of the antimicrobials, i.e., the result keeps its original category instead of being reduced to only S or R. If antimicrobials have an equally ranked result, `"S"` is preferred over `"WT"`, and `"R"` over `"NWT"` and `"NS"`. The value `"NI"` (non-interpretable) is considered a missing result.
|
#' This is an example for two antimicrobials, Drug A and Drug B (the order of the antimicrobials does not matter):
|
||||||
#'
|
|
||||||
#' A missing result can only be ignored if the result of the combination is susceptible regardless of the missing result, which depends on the `only_all_tested` argument and on the guideline: under EUCAST, the 'I' category is considered susceptible (*susceptible, increased exposure*), and under CLSI, it is not. This is an example for two antimicrobials, Drug A and Drug B (the order of the antimicrobials does not matter):
|
|
||||||
#'
|
#'
|
||||||
#' ```
|
#' ```
|
||||||
#' -------------------------------------------------------------------------
|
#' -------------------------------------------------------------------------
|
||||||
@@ -86,6 +80,7 @@
|
|||||||
#' if (require("dplyr")) {
|
#' if (require("dplyr")) {
|
||||||
#' # create a new variable for piperacillin/tazobactam + gentamicin
|
#' # create a new variable for piperacillin/tazobactam + gentamicin
|
||||||
#' example_isolates %>%
|
#' example_isolates %>%
|
||||||
|
#' filter(!is.na(TZP)) %>%
|
||||||
#' mutate(TZP_GEN = sir_combine(TZP, GEN)) %>%
|
#' mutate(TZP_GEN = sir_combine(TZP, GEN)) %>%
|
||||||
#' select(mo, TZP, GEN, TZP_GEN)
|
#' select(mo, TZP, GEN, TZP_GEN)
|
||||||
#' }
|
#' }
|
||||||
@@ -102,7 +97,10 @@
|
|||||||
#' group_by(ward) %>%
|
#' group_by(ward) %>%
|
||||||
#' summarise(
|
#' summarise(
|
||||||
#' TZP = susceptibility(TZP),
|
#' TZP = susceptibility(TZP),
|
||||||
#' TZP_GEN = susceptibility(TZP_GEN)
|
#' GEN = susceptibility(GEN),
|
||||||
|
#' TZP_GEN = susceptibility(TZP_GEN),
|
||||||
|
#' # or directly, without combining first:
|
||||||
|
#' TZP_GEN2 = susceptibility(TZP, GEN)
|
||||||
#' )
|
#' )
|
||||||
#' }
|
#' }
|
||||||
#' }
|
#' }
|
||||||
|
|||||||
@@ -170,11 +170,13 @@ example_isolates %>%
|
|||||||
#> ℹ Using column mo as input for `mo_fullname()`
|
#> ℹ Using column mo as input for `mo_fullname()`
|
||||||
#> ℹ Using column mo as input for `mo_is_gram_negative()`
|
#> ℹ Using column mo as input for `mo_is_gram_negative()`
|
||||||
#> ℹ Using column mo as input for `mo_is_intrinsic_resistant()`
|
#> ℹ Using column mo as input for `mo_is_intrinsic_resistant()`
|
||||||
#> ℹ Determining intrinsic resistance based on 'EUCAST Expected Resistant Phenotypes' v1.2 (2023).
|
#> ℹ Determining intrinsic resistance based on 'EUCAST Expected
|
||||||
#> This note will be shown once per session.
|
#> Resistant Phenotypes' v1.2 (2023). This note will be shown
|
||||||
#> ℹ For `aminoglycosides()` using columns GEN (gentamicin), TOB (tobramycin), AMK (amikacin), and KAN
|
#> once per session.
|
||||||
#> (kanamycin)
|
#> ℹ For `aminoglycosides()` using columns GEN (gentamicin), TOB
|
||||||
#> ℹ For `carbapenems()` using columns IPM (imipenem) and MEM (meropenem)
|
#> (tobramycin), AMK (amikacin), and KAN (kanamycin)
|
||||||
|
#> ℹ For `carbapenems()` using columns IPM (imipenem) and MEM
|
||||||
|
#> (meropenem)
|
||||||
#> # A tibble: 35 × 7
|
#> # A tibble: 35 × 7
|
||||||
#> bacteria GEN TOB AMK KAN IPM MEM
|
#> bacteria GEN TOB AMK KAN IPM MEM
|
||||||
#> <chr> <sir> <sir> <sir> <sir> <sir> <sir>
|
#> <chr> <sir> <sir> <sir> <sir> <sir> <sir>
|
||||||
@@ -251,7 +253,8 @@ for tracking resistance per species over time:
|
|||||||
antibiogram(example_isolates,
|
antibiogram(example_isolates,
|
||||||
mo_transform = "gramstain",
|
mo_transform = "gramstain",
|
||||||
antimicrobials = c("AMC", carbapenems(), "TZP"))
|
antimicrobials = c("AMC", carbapenems(), "TZP"))
|
||||||
#> ℹ For `carbapenems()` using columns IPM (imipenem) and MEM (meropenem)
|
#> ℹ For `carbapenems()` using columns IPM (imipenem) and MEM
|
||||||
|
#> (meropenem)
|
||||||
```
|
```
|
||||||
|
|
||||||
| Pathogen | Amoxicillin/clavulanic acid | Imipenem | Meropenem | Piperacillin/tazobactam |
|
| Pathogen | Amoxicillin/clavulanic acid | Imipenem | Meropenem | Piperacillin/tazobactam |
|
||||||
@@ -366,15 +369,16 @@ out <- example_isolates %>%
|
|||||||
# calculate AMR using resistance(), over all aminoglycosides and polymyxins:
|
# calculate AMR using resistance(), over all aminoglycosides and polymyxins:
|
||||||
summarise(across(c(aminoglycosides(), polymyxins()),
|
summarise(across(c(aminoglycosides(), polymyxins()),
|
||||||
resistance))
|
resistance))
|
||||||
#> ℹ For `aminoglycosides()` using columns GEN (gentamicin), TOB (tobramycin), AMK (amikacin), and KAN
|
#> ℹ For `aminoglycosides()` using columns GEN (gentamicin), TOB
|
||||||
#> (kanamycin)
|
#> (tobramycin), AMK (amikacin), and KAN (kanamycin)
|
||||||
#> ℹ For `polymyxins()` using column COL (colistin)
|
#> ℹ For `polymyxins()` using column COL (colistin)
|
||||||
#> Warning: There was 1 warning in `summarise()`.
|
#> Warning: There was 1 warning in `summarise()`.
|
||||||
#> ℹ In argument: `across(c(aminoglycosides(), polymyxins()), resistance)`.
|
#> ℹ In argument: `across(c(aminoglycosides(), polymyxins()),
|
||||||
|
#> resistance)`.
|
||||||
#> ℹ In group 3: `ward = "Outpatient"`.
|
#> ℹ In group 3: `ward = "Outpatient"`.
|
||||||
#> Caused by warning:
|
#> Caused by warning:
|
||||||
#> ! Introducing NA: only 23 results available for KAN in group: ward = "Outpatient" (whilst `minimum =
|
#> ! Introducing NA: only 23 results available for KAN in group:
|
||||||
#> 30`).
|
#> ward = "Outpatient" (whilst `minimum = 30`).
|
||||||
out
|
out
|
||||||
#> # A tibble: 3 × 6
|
#> # A tibble: 3 × 6
|
||||||
#> ward GEN TOB AMK KAN COL
|
#> ward GEN TOB AMK KAN COL
|
||||||
|
|||||||
+3
-9
@@ -271,17 +271,11 @@ For the full mathematical derivation and worked examples, see the \href{https://
|
|||||||
|
|
||||||
\section{Combination Therapy}{
|
\section{Combination Therapy}{
|
||||||
|
|
||||||
A combination of antimicrobials is considered as good as its most active antimicrobial. Results are ranked as follows, from best to worst:
|
A combination of antimicrobials is considered as good as its most active antimicrobial: \code{"S"} is preferred over \code{"WT"}, and \code{"R"} over \code{"NWT"} and \code{"NS"}. The value \code{"NI"} (non-interpretable) is considered a missing result.
|
||||||
\enumerate{
|
|
||||||
\item \code{"S"} and \code{"WT"}
|
|
||||||
\item \code{"SDD"}
|
|
||||||
\item \code{"I"}
|
|
||||||
\item \code{"R"}, \code{"NWT"}, and \code{"NS"}
|
|
||||||
}
|
|
||||||
|
|
||||||
The result of the combination is the best result of the antimicrobials, i.e., the result keeps its original category instead of being reduced to only S or R. If antimicrobials have an equally ranked result, \code{"S"} is preferred over \code{"WT"}, and \code{"R"} over \code{"NWT"} and \code{"NS"}. The value \code{"NI"} (non-interpretable) is considered a missing result.
|
A missing result can only be ignored if the result of the combination is susceptible regardless of the missing result, which depends on the \code{only_all_tested} argument and on the guideline: under EUCAST, the 'I' category is considered susceptible (\emph{susceptible, increased exposure}), and under CLSI, it is not.
|
||||||
|
|
||||||
A missing result can only be ignored if the result of the combination is susceptible regardless of the missing result, which depends on the \code{only_all_tested} argument and on the guideline: under EUCAST, the 'I' category is considered susceptible (\emph{susceptible, increased exposure}), and under CLSI, it is not. This is an example for two antimicrobials, Drug A and Drug B (the order of the antimicrobials does not matter):
|
This is an example for two antimicrobials, Drug A and Drug B (the order of the antimicrobials does not matter):
|
||||||
|
|
||||||
\if{html}{\out{<div class="sourceCode">}}\preformatted{-------------------------------------------------------------------------
|
\if{html}{\out{<div class="sourceCode">}}\preformatted{-------------------------------------------------------------------------
|
||||||
Result of the combination
|
Result of the combination
|
||||||
|
|||||||
+3
-9
@@ -92,17 +92,11 @@ This AMR package follows insight; use \code{\link[=susceptibility]{susceptibilit
|
|||||||
|
|
||||||
\section{Combination Therapy}{
|
\section{Combination Therapy}{
|
||||||
|
|
||||||
A combination of antimicrobials is considered as good as its most active antimicrobial. Results are ranked as follows, from best to worst:
|
A combination of antimicrobials is considered as good as its most active antimicrobial: \code{"S"} is preferred over \code{"WT"}, and \code{"R"} over \code{"NWT"} and \code{"NS"}. The value \code{"NI"} (non-interpretable) is considered a missing result.
|
||||||
\enumerate{
|
|
||||||
\item \code{"S"} and \code{"WT"}
|
|
||||||
\item \code{"SDD"}
|
|
||||||
\item \code{"I"}
|
|
||||||
\item \code{"R"}, \code{"NWT"}, and \code{"NS"}
|
|
||||||
}
|
|
||||||
|
|
||||||
The result of the combination is the best result of the antimicrobials, i.e., the result keeps its original category instead of being reduced to only S or R. If antimicrobials have an equally ranked result, \code{"S"} is preferred over \code{"WT"}, and \code{"R"} over \code{"NWT"} and \code{"NS"}. The value \code{"NI"} (non-interpretable) is considered a missing result.
|
A missing result can only be ignored if the result of the combination is susceptible regardless of the missing result, which depends on the \code{only_all_tested} argument and on the guideline: under EUCAST, the 'I' category is considered susceptible (\emph{susceptible, increased exposure}), and under CLSI, it is not.
|
||||||
|
|
||||||
A missing result can only be ignored if the result of the combination is susceptible regardless of the missing result, which depends on the \code{only_all_tested} argument and on the guideline: under EUCAST, the 'I' category is considered susceptible (\emph{susceptible, increased exposure}), and under CLSI, it is not. This is an example for two antimicrobials, Drug A and Drug B (the order of the antimicrobials does not matter):
|
This is an example for two antimicrobials, Drug A and Drug B (the order of the antimicrobials does not matter):
|
||||||
|
|
||||||
\if{html}{\out{<div class="sourceCode">}}\preformatted{-------------------------------------------------------------------------
|
\if{html}{\out{<div class="sourceCode">}}\preformatted{-------------------------------------------------------------------------
|
||||||
Result of the combination
|
Result of the combination
|
||||||
|
|||||||
+3
-9
@@ -135,17 +135,11 @@ This AMR package follows insight; use \code{\link[=susceptibility]{susceptibilit
|
|||||||
|
|
||||||
\section{Combination Therapy}{
|
\section{Combination Therapy}{
|
||||||
|
|
||||||
A combination of antimicrobials is considered as good as its most active antimicrobial. Results are ranked as follows, from best to worst:
|
A combination of antimicrobials is considered as good as its most active antimicrobial: \code{"S"} is preferred over \code{"WT"}, and \code{"R"} over \code{"NWT"} and \code{"NS"}. The value \code{"NI"} (non-interpretable) is considered a missing result.
|
||||||
\enumerate{
|
|
||||||
\item \code{"S"} and \code{"WT"}
|
|
||||||
\item \code{"SDD"}
|
|
||||||
\item \code{"I"}
|
|
||||||
\item \code{"R"}, \code{"NWT"}, and \code{"NS"}
|
|
||||||
}
|
|
||||||
|
|
||||||
The result of the combination is the best result of the antimicrobials, i.e., the result keeps its original category instead of being reduced to only S or R. If antimicrobials have an equally ranked result, \code{"S"} is preferred over \code{"WT"}, and \code{"R"} over \code{"NWT"} and \code{"NS"}. The value \code{"NI"} (non-interpretable) is considered a missing result.
|
A missing result can only be ignored if the result of the combination is susceptible regardless of the missing result, which depends on the \code{only_all_tested} argument and on the guideline: under EUCAST, the 'I' category is considered susceptible (\emph{susceptible, increased exposure}), and under CLSI, it is not.
|
||||||
|
|
||||||
A missing result can only be ignored if the result of the combination is susceptible regardless of the missing result, which depends on the \code{only_all_tested} argument and on the guideline: under EUCAST, the 'I' category is considered susceptible (\emph{susceptible, increased exposure}), and under CLSI, it is not. This is an example for two antimicrobials, Drug A and Drug B (the order of the antimicrobials does not matter):
|
This is an example for two antimicrobials, Drug A and Drug B (the order of the antimicrobials does not matter):
|
||||||
|
|
||||||
\if{html}{\out{<div class="sourceCode">}}\preformatted{-------------------------------------------------------------------------
|
\if{html}{\out{<div class="sourceCode">}}\preformatted{-------------------------------------------------------------------------
|
||||||
Result of the combination
|
Result of the combination
|
||||||
|
|||||||
+9
-11
@@ -21,23 +21,17 @@ sir_combine(
|
|||||||
A \code{\link{sir}} vector with the same length as the input.
|
A \code{\link{sir}} vector with the same length as the input.
|
||||||
}
|
}
|
||||||
\description{
|
\description{
|
||||||
Combine the SIR results of two or more antimicrobials into one SIR result per isolate, e.g. to create a variable \code{TZP_GEN} for the combination therapy of piperacillin/tazobactam with gentamicin. The result is the best result of the antimicrobials, as a combination therapy covers the isolate if any of its antimicrobials is active. See \emph{Combination Therapy} below for the exact rules.
|
Combine the SIR results of two or more antimicrobials into one SIR result per isolate, e.g. to create a variable for the combination therapy of piperacillin/tazobactam with gentamicin. The result is the best result of the antimicrobials, as a combination therapy covers the isolate if any of its antimicrobials is active. See \emph{Combination Therapy} below for the exact rules.
|
||||||
|
|
||||||
The same rules are used by \code{\link[=antibiogram]{antibiogram()}} and \code{\link[=wisca]{wisca()}} for combination antibiograms, and by the \code{\link[=count]{count_*()}} and \code{\link[=proportion]{proportion_*()}} functions when more than one variable is used, so the result of \code{\link[=sir_combine]{sir_combine()}} can be used in any further analysis.
|
The same rules are used by \code{\link[=antibiogram]{antibiogram()}} and \code{\link[=wisca]{wisca()}} for combination antibiograms, and by the \code{\link[=count]{count_*()}} and \code{\link[=proportion]{proportion_*()}} functions when more than one variable is used, so the result of \code{\link[=sir_combine]{sir_combine()}} can be used in any further analysis.
|
||||||
}
|
}
|
||||||
\section{Combination Therapy}{
|
\section{Combination Therapy}{
|
||||||
|
|
||||||
A combination of antimicrobials is considered as good as its most active antimicrobial. Results are ranked as follows, from best to worst:
|
A combination of antimicrobials is considered as good as its most active antimicrobial: \code{"S"} is preferred over \code{"WT"}, and \code{"R"} over \code{"NWT"} and \code{"NS"}. The value \code{"NI"} (non-interpretable) is considered a missing result.
|
||||||
\enumerate{
|
|
||||||
\item \code{"S"} and \code{"WT"}
|
|
||||||
\item \code{"SDD"}
|
|
||||||
\item \code{"I"}
|
|
||||||
\item \code{"R"}, \code{"NWT"}, and \code{"NS"}
|
|
||||||
}
|
|
||||||
|
|
||||||
The result of the combination is the best result of the antimicrobials, i.e., the result keeps its original category instead of being reduced to only S or R. If antimicrobials have an equally ranked result, \code{"S"} is preferred over \code{"WT"}, and \code{"R"} over \code{"NWT"} and \code{"NS"}. The value \code{"NI"} (non-interpretable) is considered a missing result.
|
A missing result can only be ignored if the result of the combination is susceptible regardless of the missing result, which depends on the \code{only_all_tested} argument and on the guideline: under EUCAST, the 'I' category is considered susceptible (\emph{susceptible, increased exposure}), and under CLSI, it is not.
|
||||||
|
|
||||||
A missing result can only be ignored if the result of the combination is susceptible regardless of the missing result, which depends on the \code{only_all_tested} argument and on the guideline: under EUCAST, the 'I' category is considered susceptible (\emph{susceptible, increased exposure}), and under CLSI, it is not. This is an example for two antimicrobials, Drug A and Drug B (the order of the antimicrobials does not matter):
|
This is an example for two antimicrobials, Drug A and Drug B (the order of the antimicrobials does not matter):
|
||||||
|
|
||||||
\if{html}{\out{<div class="sourceCode">}}\preformatted{-------------------------------------------------------------------------
|
\if{html}{\out{<div class="sourceCode">}}\preformatted{-------------------------------------------------------------------------
|
||||||
Result of the combination
|
Result of the combination
|
||||||
@@ -75,6 +69,7 @@ susceptibility(sir_combine(drug_a, drug_b), minimum = 0)
|
|||||||
if (require("dplyr")) {
|
if (require("dplyr")) {
|
||||||
# create a new variable for piperacillin/tazobactam + gentamicin
|
# create a new variable for piperacillin/tazobactam + gentamicin
|
||||||
example_isolates \%>\%
|
example_isolates \%>\%
|
||||||
|
filter(!is.na(TZP)) \%>\%
|
||||||
mutate(TZP_GEN = sir_combine(TZP, GEN)) \%>\%
|
mutate(TZP_GEN = sir_combine(TZP, GEN)) \%>\%
|
||||||
select(mo, TZP, GEN, TZP_GEN)
|
select(mo, TZP, GEN, TZP_GEN)
|
||||||
}
|
}
|
||||||
@@ -91,7 +86,10 @@ if (require("dplyr")) {
|
|||||||
group_by(ward) \%>\%
|
group_by(ward) \%>\%
|
||||||
summarise(
|
summarise(
|
||||||
TZP = susceptibility(TZP),
|
TZP = susceptibility(TZP),
|
||||||
TZP_GEN = susceptibility(TZP_GEN)
|
GEN = susceptibility(GEN),
|
||||||
|
TZP_GEN = susceptibility(TZP_GEN),
|
||||||
|
# or directly, without combining first:
|
||||||
|
TZP_GEN2 = susceptibility(TZP, GEN)
|
||||||
)
|
)
|
||||||
}
|
}
|
||||||
}
|
}
|
||||||
|
|||||||
Reference in new issue
Block a user